Novel silver carp bacterial septicemia drug and preparation method thereof

• Main Author: MAO JIANBING
• Format: Patent
• Language: Chinese; English
• Published: 13.06.2017
• Subjects: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS; FODDER; FOODS OR FOODSTUFFS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The invention provides a novel silver carp bacterial septicemia drug which is characterized by comprising the following components in parts by weight: 0.1-0.3 part of enrofloxacin, 0.2-0.5 part of sodium hydroxide, 0.004-0.008 part of phagostimulant, 3-5 parts of pure water and 94.942-94.496 parts of fodder, wherein the sodium hydroxide is food-grade sodium hydroxide, the fodder is one or mixture of rice bran and bran, and the rice bran is screened by a 80-mesh sieve. The drug provided by the invention is directly eaten by fish, can participate into fish metabolism, is more thorough in treatment and is more reliable in curative effect. Moreover, the novel silver carp bacterial septicemia drug does not damage water quality, has no any adverse influence on the growth of plankton of water and thus has no influence on the growth of silver carp. 本发明提供了种新型鲢鳙鱼细菌性败血症药物，其特征在于：按重量份数计算，包括混合的以下组分：恩诺沙星0.1份-0.3份,氢氧化钠0.2份-0.5份,诱食剂0.004份-0.008份，纯水3份-5份，饲料物94.942份-94.496份，其中所述氢氧化钠为食品级氢氧化钠，所述饲料物为米糠、麸皮的种或其混合物，其中米糠为过80目筛的米糠。本发明提